prenyl transferase

CAT # Inoa Huahana wehewehe
CPD3233 AZD-3409 ʻO AZD-3409 kahi mea paʻa prenyl transferase. Ua hōʻike ʻo AZD-3409 i ka mana kiʻekiʻe ma mua o lonafarnib. ʻO ka mean IC (50) no ka cytotoxicity o AZD3409 he 510 i loko o nā pūnaewele MEF, 10,600 i nā pūnaewele A549 a me 6,170 i nā pūnaewele MCF7, kēlā me kēia. I loko o kēia mau pūnaewele, ʻo ka IC (50) no ka hana FTase o AZD3409 mai 3.0 a 14.2 nM a me lonafarnib mai 0.26 a 31.3 nM. Kāohi ʻo AZD3409 i ka farnesylation i kahi kiʻekiʻe ma mua o ka geranylgeranylation. ʻAʻole hiki ke hoʻopili ʻia ka pale ʻana o ka farnesylation a me ka geranylgeranylation i ka hana antiproliferative o ka lāʻau. Hiki paha iā AZD3409 ke ʻeleu i ka maʻi maʻi maʻi umauma gefitinib.
,

Kāhea iā mā˚ou

Ninau

Nuhou Hou

  • ʻO 7 ʻoi loa ma ka noiʻi lāʻau lapaʻau ma 2018

    ʻO 7 ʻoi loa i ka noiʻi lāʻau lapaʻau I...

    Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi ʻenehana paʻakikī a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho i mua ...

  • ARS-1620: He mea hoʻohiki hou no nā maʻi maʻi KRAS-mutant

    ARS-1620: He mea hoʻohiki hou no K...

    Wahi a kahi noiʻi i paʻi ʻia ma Cell, ua hoʻomohala nā mea noiʻi i kahi inhibitor kūikawā no KRASG12C i kapa ʻia ʻo ARS-1602 i hoʻoulu i ka regression tumor i nā ʻiole. "Ke hāʻawi nei kēia haʻawina i nā hōʻike vivo e hiki ke lilo i mutant KRAS ...

  • Loaʻa iā AstraZeneca ka hoʻoikaika kānāwai no nā lāʻau lapaʻau oncology

    Loaʻa iā AstraZeneca ka hoʻonui hoʻoponopono no...

    Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ...

WhatsApp Online Chat !